UPDATE: Alder Agreed To Withdraw Appeal With European Patent Office In Opposition To Teva; Co. Will Immediately Pay $25M To Teva With Another $25M Payment Upon Approval Of Eptinezumab BLA, 2 $75M Milestone Payments And 5-7% Royalty